Northwest Biotherapeutics | NWBO - Interest Expense On Debt


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Northwest Biotherapeutics

Northwest Biotherapeutics reported $1.03M in Interest Expense on Debt for its fiscal quarter ending in March of 2023.


Interest Expense On Debt Change
Bristol-Myers Squibb BMY:US USD 288M 6M
CTI Biopharma CTIC:US USD 5.05M 276K
Infinity Pharmaceuticals INFI:US USD 45K 0
Northwest Biotherapeutics NWBO:US USD 1.03M 194K
Pfizer PFE:US USD 318M 5M
Roche Holding ROG:VX 348M 92M